Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the editors. Following a request from the authors, the editors of eBioMedicine are retracting the above article. A Corrigendum for the paper was originally issued on May 2020. However, the editors became aware of several potential figure panel duplications between Figure 7c of the paper and Figure 7a of an unrelated manuscript published by Zheng and colleagues, entitled "MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK" Oncotarget. 2017; 8:100227–100241. https://doi.org/10.18632/oncotarget.22151. Given the nature and extent of the image duplications found, the editors of eBioMedicine no longer have confidence in the integrity of the data and retract both the paper and related Corrigendum. RETRACTED: Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66–78]This article has been retracted: please see Elsevier Policy on Article Withdrawal ( https://www.elsevier.com/locate/withdrawalpolicy ). Full-Text PDF Open Access

Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Retraction: Cell Membrane Based Biomimetic Nanocomposites for Targeted Therapy of Drug Resistant EGFR-mutated Lung Cancer

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

Retraction: PEG-poly(amino acid)s/EpCAM aptamer multifunctional nanoparticles arrest the growth and metastasis of colorectal cancer

Retracted: Observation of the Curative Effect of Acupuncture for Tonifying Kidney and Removing Blood Stasis Combined with Radiofrequency Surgery in Patients with NSCLC and the Diagnostic Efficacy of Combined Detection of NTx, BGP, and CYFRA21-1 in the Occurrence of Bone Metastases

Retracted: Efficacy of Drug-Eluting Bead Transarterial Chemoembolization in the Treatment of Colorectal Cancer Liver Metastasis

RETRACTION: An MSN-PEG-IP drug delivery system and IL13R2 as targeted therapy for glioma (Retraction of Vol 9, Pg 8970, 2017)

Retraction Notice To: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.

Retraction Note: Exosome-transmitted Mir-128-3p Increase Chemosensitivity of Oxaliplatin-Resistant Colorectal Cancer

RETRACTED: Mir-539 Enhances Chemosensitivity to Cisplatin in Non-Small Cell Lung Cancer by Targeting DCLK1

Retracted: Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer

Retraction Notice To: Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer

[Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer

Retraction Note To: the Circrna Circagfg1 Acts As a Sponge of Mir-195-5p to Promote Triple-Negative Breast Cancer Progression Through Regulating CCNE1 Expression

RETRACTION: Retraction Note: Ethaselen Synergizes with Oxaliplatin in Tumor Growth Inhibition by Inducing ROS Production and Inhibiting TrxR1 Activity in Gastric Cancer (retraction of Vol 40, Art No 260, 2021)

Retraction of “Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial”

Retinoic acid-incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells

Retraction Notice to “corrigendum to ‘Microrna-134 Prevents the Progression of Esophageal Squamous Cell Carcinoma Via the PLXNA1-mediated MAPK Signalling Pathway’ [ebiomedicine 46 (2019) 66–78]” [ebiomedicine 55 (2020) 102772]

RETRACTED:Inhibition of KRAS Gene Mutation on Non-Small Cell Lung Cancer and Its Effect on Circulating Tumor Cells

Reduced Mir-363-3p Expression in Non-Small Cell Lung Cancer is Associated with Gemcitabine Resistance Via Targeting of CUL4A.

[Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‐mutated lung cancer cells